{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:51:55Z","timestamp":1784069515153,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.rbmo.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T01:41:39Z","timestamp":1568598099000},"page":"331-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fully human glyco-optimized recombinant FSH (follitropin epsilon) \u2013 a randomized, comparator-controlled phase II clinical trial"],"prefix":"10.1016","volume":"40","author":[{"given":"Georg","family":"Griesinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"St\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Goletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Tandler-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.09.003_bib0001","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/humrep\/dex220","article-title":"A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials","volume":"32","author":"Abd-Elaziz","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0038-1635488","article-title":"Descriptive data analysis: a concept between confirmatory and exploratory data analysis","volume":"26","author":"Abt","year":"1987","journal-title":"Methods Inf. Med."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0003","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0004","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone\u2013stratified, dose\u2013response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0005","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0006","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/deq125","article-title":"Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles","volume":"25","author":"Bosch","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0007","unstructured":"EMA, 2006. Note for guidance on Good Clinical Practice (CPMP\/ICH\/135\/95).https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e6-r1-guideline-good-clinical-practice_en.pdf (last access on Oct 24, 2019)."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0008","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.fertnstert.2005.09.035","article-title":"A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome","volume":"85","author":"Kok","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/humrep\/dex334","article-title":"The number of oocytes retrieved during IVF: a balance between efficacy and safety","volume":"33","author":"Magnusson","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0011","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jcph.328","article-title":"Different pharmacokinetic and pharmacodynamics properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line","volume":"54","author":"Olsson","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0012","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilisation cycle","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0013","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1095\/biolreprod.104.032003","article-title":"Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro","volume":"72","author":"Roberts","year":"2005","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0014","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/AOG.0b013e3181d9d421","article-title":"CONSORT 2010. statement: updated guidelines for reporting parallel group randomized trials","volume":"115","author":"Schulz","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1210\/endo-53-6-604","article-title":"Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin","volume":"53","author":"Steelman","year":"1953","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2019.09.003_bib0016","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/humrep\/16.4.757","article-title":"Differential effects of repeated ovarian stimulation on cytoplasmic and spindle organization in metaphase II mouse oocytes matured in vivo and in vitro","volume":"16","author":"Van Blerkom","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.09.003_bib0017","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/humupd\/dmt014","article-title":"Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles","volume":"19","author":"Venetis","year":"2013","journal-title":"Hum. Reprod. Update."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319307138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319307138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:16:48Z","timestamp":1761466608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319307138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1472648319307138"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.09.003","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fully human glyco-optimized recombinant FSH (follitropin epsilon) \u2013 a randomized, comparator-controlled phase II clinical trial","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}]}}